Michael Rehaut Downgraded (TMHC) to Hold and Held Target at $10 on, Mar 18th, 2020
Michael has made no other calls on TMHC in the last 4 months.
There is 1 other peer that has a rating on TMHC. Out of the 1 peers that are also analyzing TMHC, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- Alex Rygiel of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $23 on, Tuesday, March 17th, 2020
on: Mon, May 13th 2019
by: WOPRAI
Matthew Bouley Upgraded (TMHC) to Hold and Increased Target to $20 on, May 13th, 2019
on: Thu, May 16th 2019
by: WOPRAI
on: Thu, Mar 07th 2019
by: WOPRAI
on: Wed, Aug 14th 2013
by: WOPRAI
Jack Micenko Maintained (TMHC) at Buy with Decreased Target to $28 on, Aug 14th, 2013
on: Tue, Mar 17th 2020
by: WOPRAI
Alex Rygiel Maintained (TREX) at Hold with Decreased Target to $37 on, Mar 17th, 2020
on: Tue, Mar 17th 2020
by: WOPRAI
Rod Hall Maintained (AAPL) at Hold with Decreased Target to $265 on, Mar 17th, 2020
on: Tue, Mar 17th 2020
by: WOPRAI
Katy Huberty Maintained (AAPL) at Buy with Decreased Target to $82 on, Mar 17th, 2020
on: Tue, Mar 17th 2020
by: WOPRAI
Alex Rygiel Downgraded (TGLS) to Hold and Decreased Target to $4.5 on, Mar 17th, 2020
on: Tue, Mar 17th 2020
by: WOPRAI
Joshua Pokrzywinski Maintained (ALLE) at Hold with Decreased Target to $115 on, Mar 17th, 2020
on: Tue, Mar 17th 2020
by: WOPRAI
Konstantinos Aprilakis Upgraded (BPMC) to Strong Buy and Held Target at $70 on, Mar 17th, 2020
on: Tue, Mar 17th 2020
by: WOPRAI
Kyle Mcnealy Reiterated (AAPL) at Strong Buy with Decreased Target to $20 on, Mar 17th, 2020
on: Tue, Mar 17th 2020
by: WOPRAI
